BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 11928222)

  • 1. [Involvement of polynuclear eosinophils and of type TH2 immune responses in allograft rejections].
    Le Moine A
    Bull Mem Acad R Med Belg; 2001; 156(6 Pt 2):318-28. PubMed ID: 11928222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-5 mediates eosinophilic rejection of MHC class II-disparate skin allografts in mice.
    Le Moine A; Surquin M; Demoor FX; Noël JC; Nahori MA; Pretolani M; Flamand V; Braun MY; Goldman M; Abramowicz D
    J Immunol; 1999 Oct; 163(7):3778-84. PubMed ID: 10490975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical roles for IL-4, IL-5, and eosinophils in chronic skin allograft rejection.
    Le Moine A; Flamand V; Demoor FX; Noël JC; Surquin M; Kiss R; Nahori MA; Pretolani M; Goldman M; Abramowicz D
    J Clin Invest; 1999 Jun; 103(12):1659-67. PubMed ID: 10377172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-9 promotes eosinophilic rejection of mouse heart allografts.
    Poulin LF; Richard M; Le Moine A; Kiss R; McKenzie AN; Goldman M; Renauld JC; Van Snick J; Braun MY
    Transplantation; 2003 Aug; 76(3):572-7. PubMed ID: 12923446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-9 stimulates the production of interleukin-5 in CD4+ T cells.
    Poulin LF; Habran C; Stordeur P; Goldman M; McKenzie A; Van Snick J; Renauld JC; Braun MY
    Eur Cytokine Netw; 2005 Sep; 16(3):233-9. PubMed ID: 16266865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Graft rejection mediated by CD4+ T cells via indirect recognition of alloantigen is associated with a dominant Th2 response.
    Csencsits K; Wood SC; Lu G; Magee JC; Eichwald EJ; Chang CH; Bishop DK
    Eur J Immunol; 2005 Mar; 35(3):843-51. PubMed ID: 15714582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MHC-matched corneal allograft rejection in an IFN-gamma/IL-17-independent manner in C57BL/6 mice.
    Yamada J; Hamuro J; Fukushima A; Ohteki T; Terai K; Iwakura Y; Yagita H; Kinoshita S
    Invest Ophthalmol Vis Sci; 2009 May; 50(5):2139-46. PubMed ID: 19136699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the Th1/Th2 paradigm in transplantation: interferon-gamma deficiency converts Th1-type proislet allograft rejection to a Th2-type xenograft-like response.
    Simeonovic CJ; Townsend MJ; Karupiah G; Wilson JD; Zarb JC; Mann DA; Young IG
    Cell Transplant; 1999; 8(4):365-73. PubMed ID: 10478716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD30 antigen: not a physiological marker for TH2 cells but an important costimulator molecule in the regulation of the balance between TH1/TH2 response.
    Pellegrini P; Berghella AM; Contasta I; Adorno D
    Transpl Immunol; 2003; 12(1):49-61. PubMed ID: 14551032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-4 deficiency prevents eosinophilic rejection and uncovers a role for neutrophils in the rejection of MHC class II disparate skin grafts.
    Surquin M; Le Moine A; Flamand V; Rombaut K; Demoor FX; Salmon I; Goldman M; Abramowicz D
    Transplantation; 2005 Nov; 80(10):1485-92. PubMed ID: 16340795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone marrow-derived immature dendritic cells prime in vivo alloreactive T cells for interleukin-4-dependent rejection of major histocompatibility complex class II antigen-disparate cardiac allograft.
    Buonocore S; Flamand V; Goldman M; Braun MY
    Transplantation; 2003 Feb; 75(3):407-13. PubMed ID: 12589166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of nitric oxide during graft rejection is regulated by the Th1/Th2 balance, the arginase activity, and L-arginine metabolism.
    Holán V; Pindjáková J; Krulová M; Neuwirth A; Fric J; Zajícová A
    Transplantation; 2006 Jun; 81(12):1708-15. PubMed ID: 16794538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic cardiac allograft rejection in a rat model disparate for one single class I MHC molecule is associated with indirect recognition by CD4(+) T cells.
    Shirwan H; Mhoyan A; Yolcu ES; Que X; Ibrahim S
    Transpl Immunol; 2003; 11(2):179-85. PubMed ID: 12799202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling anti-tumor Th1 and Th2 immunity in the rejection of melanoma.
    Eftimie R; Bramson JL; Earn DJ
    J Theor Biol; 2010 Aug; 265(3):467-80. PubMed ID: 20450922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predominant expression of the Th2 response in chronic cardiac allograft rejection.
    Mhoyan A; Wu GD; Kakoulidis TP; Que X; Yolcu ES; Cramer DV; Shirwan H
    Transpl Int; 2003 Aug; 16(8):464-73. PubMed ID: 12712237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of CD4+ and CD8+ T cells and interferon-gamma to the progress of chronic rejection of kidney allografts: the Th1 response mediates both acute and chronic rejection.
    Obata F; Yoshida K; Ohkubo M; Ikeda Y; Taoka Y; Takeuchi Y; Shinohara N; Endo T; Baba S
    Transpl Immunol; 2005 Mar; 14(1):21-5. PubMed ID: 15814278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High expression of TIAF-1 in chronic kidney and liver allograft rejection and in activated T-helper cells.
    van der Leij J; van den Berg A; Albrecht EW; Blokzijl T; Roozendaal R; Gouw AS; de Jong KP; Stegeman CA; van Goor H; Chang NS; Poppema S
    Transplantation; 2003 Jun; 75(12):2076-82. PubMed ID: 12829915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The replacement of graft endothelium by recipient-type cells conditions allograft rejection mediated by indirect pathway CD4+ T cells.
    Kapessidou Y; Habran C; Buonocore S; Flamand V; Barvais L; Goldman M; Braun MY
    Transplantation; 2006 Aug; 82(4):582-91. PubMed ID: 16958183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The replacement of graft endothelium by recipient-type cells conditions allograft rejection mediated by indirect pathway CD4(+) T cells.
    Kapessidou Y; Habran C; Buonocore S; Flamand V; Barvais L; Goldman M; Braun MY
    Transplantation; 2006 Mar; 81(5):726-35. PubMed ID: 16534475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new T-cell receptor transgenic model of the CD4+ direct pathway: level of priming determines acute versus chronic rejection.
    Brennan TV; Hoang V; Garrod KR; Liu FC; Hayden T; Kim J; Kang SM
    Transplantation; 2008 Jan; 85(2):247-55. PubMed ID: 18212630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.